SuperCom Reports Record Revenue and Record EBITDA of $4 Million in the Second Quarter of 2026

SuperCom Ltd. (NASDAQ:SPCB) reported Q2 2026 revenue of $8.1 million, up 13.3% year over year, and record EBITDA of $4.0 million. Non-GAAP net income was $2.9 million, with Non-GAAP EPS of $0.52. For H1 2026, revenue rose to $15.7 million and EBITDA to $7.3 million. The company also cited multiple new electronic monitoring contract wins and a $7.5 million registered direct offering.

Original reporting
Published Aug 13, 2026, 1:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SuperCom Reports Record Revenue and Record EBITDA of $4 Million in the Second Quarter of 2026 — source image
Decision brief

The 30-second read

$SPCBBullishMed
01

Why it matters

The combination of record Q2 revenue and EBITDA, accelerating EM ARR run-rate, and multiple newly signed or launched national and county contracts is likely to shift expectations for recurring revenue growth and operating leverage.

02

Market read

Traders can reassess SPCB’s growth trajectory and profitability outlook based on fresh quarterly numbers and disclosed contract displacement/expansion activity.

03

What to watch

The release mentions a registered direct offering and multiple contract wins, but does not quantify backlog, cash flow, or specific revenue recognition timing for the newly won programs.

Relevance 8/10Novelty 8/10Timing: pre-market today, ahead of the Aug 13 10 a.m. ET conference call

Background

SuperCom is a GovTech/electronic monitoring and cybersecurity provider, reporting quarterly results and emphasizing recurring revenue growth from EM programs.

Company-level read

Ticker impact

$SPCBBullishMedium confidence
Context

SuperCom reported Q2 2026 revenue of $8.1M (+13.3% YoY) and EBITDA of $4.0M (+58% YoY), plus multiple new EM contract wins.

Expected impact

Likely positive bias for the stock into and after the Aug 13 call, with upside sensitivity to any incremental contract/ARR details.

Evidence & confidence

The release provides fresh quarterly financial datapoints and specific contract awards (Sweden, Norway, Nevada, New York, Ohio, Michigan, etc.) plus an accelerating EM ARR run-rate, which are direct drivers for valuation and expectations.

Market effects

Reinforces demand durability for electronic monitoring and government cybersecurity/e-government vendors, potentially improving sentiment for small-cap GovTech peers.

Highlights continued Nordic and U.S. expansion, which may matter for investors tracking cross-region contract cycles.

Limited broader macro impact, but supports the narrative of recurring-revenue scaling in public-sector tech procurement.

Counterpoint

Non-GAAP metrics and FX headwinds could mask underlying cash conversion or margin sustainability, and contract budgets may not fully translate into near-term revenue timing.

Key entities

  • SuperCom Ltd.

    NASDAQ-listed GovTech and electronic monitoring provider reporting Q2 2026 results and contract wins.

  • Ordan Trabelsi

    CEO who commented on operating leverage and EM scaling.

Related articles

$SPCBMed

SuperCom (SPCB) Q3 2026 Earnings Call Transcript

SuperCom (SPCB) reported Q3 2026 revenue of $7.5M, up 21% YoY, with GAAP net income of $0.1M. Gross margin fell to 49.8% from 60.8% YoY due to a $1.3M foreign exchange loss. The company introduced SafeGenie, a cybersecurity product for AI agents, and expects growth in AI security spending. SuperCom also reduced net debt to $7M and has $12.9M in cash. SafeGenie could add new recurring revenue streams.

Med

SuperCom Ltd. Q3 2026 Earnings Call Summary

SuperCom Ltd. reported a 37% increase in nine-month EBITDA, driven by operational efficiencies, AI integration, and market expansion. The company won contracts in Europe and the U.S., acquired LCA, and plans to expand into Latin America and Asia. Revenue fluctuations in Europe were noted, and a $1.3M foreign exchange loss was recorded. Management provided guidance for a Sweden project and discussed growth initiatives like SafeGenie.

$SPCBMed

SPCB: Revenue and EBITDA grew as monitoring contracts expanded and SafeGenie entered rollout

SuperCom Ltd. reported Q3 2026 revenue growth of 21% YoY and EBITDA growth of 17%, driven by expanded electronic monitoring contracts and the rollout of SafeGenie. Foreign exchange pressure impacted GAAP operating results and gross margin. The company's growth plans are supported by a stronger balance sheet and product launches, with execution and adoption timing cited as key variables.

$SPCBMedAI 8/10

SuperCom (SPCB) Q2 2026 Earnings Call Transcript

SuperCom (SPCB) reported Q2 2026 results, citing record revenue, gross profit, and EBITDA. Revenue rose 13.3% to $8.1M, gross profit to $4.9M, and gross margin to 60%. GAAP EPS was about $0.20 and non-GAAP EPS $0.52. EBITDA increased 55.6% to $4.0M. The company also raised about $7.5M via a registered direct offering in early July.

$SPCBMedAI 8/10

SuperCom Wins New Electronic Monitoring Contract in Kansas, Expanding U.S. Presence into 19th New State

SuperCom (NASDAQ: SPCB) said it won a new electronic monitoring contract in Kansas at the county level, introducing its PureOne technology and displacing the incumbent intermediary provider. The deal uses a recurring daily active-units model, with training and deployment expected to start by end-July 2026. SuperCom cited TTM non-GAAP EBITDA of $10.3 million.